Cargando…
Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia Cells
Recent studies suggest there is a high incidence of elevated low-density lipoprotein (LDL) levels in Chronic Lymphocytic Leukemia (CLL) patients and a survival benefit from cholesterol-lowering statin drugs. The mechanisms of these observations and the kinds of patients they apply to are unclear. Us...
Autores principales: | McCaw, Lindsay, Shi, Yonghong, Wang, Guizhi, Li, You-Jun, Spaner, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233814/ https://www.ncbi.nlm.nih.gov/pubmed/27932296 http://dx.doi.org/10.1016/j.ebiom.2016.11.033 |
Ejemplares similares
-
Persistent janus kinase‐signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial
por: Spaner, David E., et al.
Publicado: (2019) -
Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo
por: Spaner, David E., et al.
Publicado: (2023) -
Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells
por: Oppermann, Sina, et al.
Publicado: (2016) -
Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia
por: Spaner, David E., et al.
Publicado: (2018) -
Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia
por: McMahon, Kaylin M., et al.
Publicado: (2017)